Observations placeholder
Tykerb
Identifier
015763
Type of Spiritual Experience
Number of hallucinations: 7
Background
A description of the experience
Lapatinib (INN), used in the form of lapatinib ditosylate, (USAN) (Tykerb/Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2)
On Dec, 29, 2016 9,372 people reported to have side effects when taking Tykerb.
Among them, 7 people (0.07%) have Hallucination
Time on Tykerb when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Dec, 25, 2016 9,372 people reported to have side effects when taking Tykerb.
Among them, 1,051 people (11.21%) have Death
Time on Tykerb when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 13.21% | 58.49% | 16.98% | 3.77% | 7.55% | 0.00% | 0.00% |
Gender of people who have Death when taking Tykerb :
| Female | Male | |
| Death | 95.20% | 4.80% |